These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 16091744)

  • 1. Melphalan-induced apoptosis in multiple myeloma cells is associated with a cleavage of Mcl-1 and Bim and a decrease in the Mcl-1/Bim complex.
    Gomez-Bougie P; Oliver L; Le Gouill S; Bataille R; Amiot M
    Oncogene; 2005 Dec; 24(54):8076-9. PubMed ID: 16091744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noxa up-regulation and Mcl-1 cleavage are associated to apoptosis induction by bortezomib in multiple myeloma.
    Gomez-Bougie P; Wuillème-Toumi S; Ménoret E; Trichet V; Robillard N; Philippe M; Bataille R; Amiot M
    Cancer Res; 2007 Jun; 67(11):5418-24. PubMed ID: 17545623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The imbalance between Bim and Mcl-1 expression controls the survival of human myeloma cells.
    Gomez-Bougie P; Bataille R; Amiot M
    Eur J Immunol; 2004 Nov; 34(11):3156-64. PubMed ID: 15459900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reciprocal protection of Mcl-1 and Bim from ubiquitin-proteasome degradation.
    Wuillème-Toumi S; Trichet V; Gomez-Bougie P; Gratas C; Bataille R; Amiot M
    Biochem Biophys Res Commun; 2007 Oct; 361(4):865-9. PubMed ID: 17681275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bim is the key mediator of glucocorticoid-induced apoptosis and of its potentiation by rapamycin in human myeloma cells.
    López-Royuela N; Balsas P; Galán-Malo P; Anel A; Marzo I; Naval J
    Biochim Biophys Acta; 2010 Feb; 1803(2):311-22. PubMed ID: 19914305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous association of Bim BH3-only protein with Mcl-1, Bcl-xL and Bcl-2 on mitochondria in human B cells.
    Gomez-Bougie P; Bataille R; Amiot M
    Eur J Immunol; 2005 Mar; 35(3):971-6. PubMed ID: 15724238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGFbeta-mediated apoptosis of Burkitt's lymphoma BL41 cells is associated with the relocation of mitochondrial BimEL.
    Clybouw C; Mchichi BE; Hadji A; Portier A; Auffredou MT; Arnoult D; Leca G; Vazquez A
    Oncogene; 2008 May; 27(24):3446-56. PubMed ID: 18193085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The BH3-only protein Bim(L) overrides Bcl-2-mediated apoptosis resistance in melanoma cells.
    Plötz M; Gillissen B; Quast SA; Berger A; Daniel PT; Eberle J
    Cancer Lett; 2013 Jul; 335(1):100-8. PubMed ID: 23402819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BECN1 and BIM interactions with MCL-1 determine fludarabine resistance in leukemic B cells.
    Sharma A; Singh K; Mazumder S; Hill BT; Kalaycio M; Almasan A
    Cell Death Dis; 2013 May; 4(5):e628. PubMed ID: 23681223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interrelated roles for Mcl-1 and BIM in regulation of TRAIL-mediated mitochondrial apoptosis.
    Han J; Goldstein LA; Gastman BR; Rabinowich H
    J Biol Chem; 2006 Apr; 281(15):10153-63. PubMed ID: 16478725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cleavage of Mcl-1 by caspases impaired its ability to counteract Bim-induced apoptosis.
    Herrant M; Jacquel A; Marchetti S; Belhacène N; Colosetti P; Luciano F; Auberger P
    Oncogene; 2004 Oct; 23(47):7863-73. PubMed ID: 15378010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bim plays a crucial role in synergistic induction of apoptosis by the histone deacetylase inhibitor SBHA and TRAIL in melanoma cells.
    Gillespie S; Borrow J; Zhang XD; Hersey P
    Apoptosis; 2006 Dec; 11(12):2251-65. PubMed ID: 17051334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crosstalk among Bcl-2 family members in B-CLL: seliciclib acts via the Mcl-1/Noxa axis and gradual exhaustion of Bcl-2 protection.
    Hallaert DY; Spijker R; Jak M; Derks IA; Alves NL; Wensveen FM; de Boer JP; de Jong D; Green SR; van Oers MH; Eldering E
    Cell Death Differ; 2007 Nov; 14(11):1958-67. PubMed ID: 17703234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ERK1/2-dependent phosphorylation of BimEL promotes its rapid dissociation from Mcl-1 and Bcl-xL.
    Ewings KE; Hadfield-Moorhouse K; Wiggins CM; Wickenden JA; Balmanno K; Gilley R; Degenhardt K; White E; Cook SJ
    EMBO J; 2007 Jun; 26(12):2856-67. PubMed ID: 17525735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of cytokine withdrawal-induced apoptosis by Mcl-1 requires interaction between Mcl-1 and Bim.
    Jamil S; Wang SW; Bondy L; Mojtabavi S; Duronio V
    Biochem Cell Biol; 2010 Oct; 88(5):809-18. PubMed ID: 20921992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation of Mcl-1 by granzyme B: implications for Bim-mediated mitochondrial apoptotic events.
    Han J; Goldstein LA; Gastman BR; Froelich CJ; Yin XM; Rabinowich H
    J Biol Chem; 2004 May; 279(21):22020-9. PubMed ID: 15014070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MEK1/2 inhibitors potentiate UCN-01 lethality in human multiple myeloma cells through a Bim-dependent mechanism.
    Pei XY; Dai Y; Tenorio S; Lu J; Harada H; Dent P; Grant S
    Blood; 2007 Sep; 110(6):2092-101. PubMed ID: 17540843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pivotal role for Mcl-1 in Bortezomib-induced apoptosis.
    Podar K; Gouill SL; Zhang J; Opferman JT; Zorn E; Tai YT; Hideshima T; Amiot M; Chauhan D; Harousseau JL; Anderson KC
    Oncogene; 2008 Jan; 27(6):721-31. PubMed ID: 17653083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mcl-1 as a buffer for proapoptotic Bcl-2 family members during TRAIL-induced apoptosis: a mechanistic basis for sorafenib (Bay 43-9006)-induced TRAIL sensitization.
    Meng XW; Lee SH; Dai H; Loegering D; Yu C; Flatten K; Schneider P; Dai NT; Kumar SK; Smith BD; Karp JE; Adjei AA; Kaufmann SH
    J Biol Chem; 2007 Oct; 282(41):29831-46. PubMed ID: 17698840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDK inhibitors upregulate BH3-only proteins to sensitize human myeloma cells to BH3 mimetic therapies.
    Chen S; Dai Y; Pei XY; Myers J; Wang L; Kramer LB; Garnett M; Schwartz DM; Su F; Simmons GL; Richey JD; Larsen DG; Dent P; Orlowski RZ; Grant S
    Cancer Res; 2012 Aug; 72(16):4225-37. PubMed ID: 22693249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.